Review Article
Cancer Immunotherapy: Priming the Host Immune Response with Live Attenuated Salmonella enterica
Table 2
Salmonella enterica as delivery system of TAA/TSA and immunomodulatory molecules.
| Species | Mutations | Heterologous molecule | Tumor-bearing mice | Antitumoral response | Reference |
| Tumor-associated antigens or tumor-specific antigens (TAA/TSA) | Salmonella Typhimurium | aroA | Antigen PSA | Prostate cancer | Cytotoxic CD8+ T-cell | [104] | aroA | L1HPV16 | Cervical cancer | IFN-γ and TNF-α secretion | [111] | aroA, sptP | Antigen p60217–225 | Fibrosarcoma | Effector and memory CD8+ T-cells | [106, 107] | VEGFR-2 | Melanoma | Specific CD8 T-cell | [109] | aroA, hisG46 | C-Raf | Lung adenoma | Humoral and T-cell responses | [105] | aroA, aroD | SipB160-HPV16E7 | Cervical cancer | Humoral response | [110] | Salmonella Typhimurium | phoP, phoQ | NY-ESO-1 | Sarcoma | NY-ESO-1-specific CD8+ T-cell response | [108] | Salmonella Typhimurium | dam, aroA | MTDH/AEG1-1 | Breast cancer and metastasis | CD8+ T-cell response | [112] |
| Immunomodulatory and apoptosis inductor molecules | Salmonella Typhimurium | purl, msbB | CCL21 | Colon and breast cancer | CD4+ and CD8+ T-cell response | [33] | LIGHT | Colon and breast cancer | Infiltration of inflammatory cells | [114] | IL-18 | Colon and breast cancer | CD4+ T-cell response and NK cells | [115] | FasL | Colon and breast cancer | Accumulation of neutrophils | [119] | Salmonella Typhimurium | cya, crp, asd | IL-2 | Osteosarcoma and metastasis | NK cells | [116, 117] | Salmonella Typhimurium | aroA | IL-4 and IL-18 | Melanoma | Increase levels of IFN-γ | [118] | aroA, hisG46 | TRAIL | Gastric cancer | Increase levels of caspases 3 and 9 | [121] | aroA, aroD | TNFα | Melanoma | NK cells | [120] |
| Clinical Trial Phase l | Salmonella Typhi | galE | VEGFR-2 | Pancreatic cancer | T-cell response | [127, 128] |
|
|
CCL21: chemokine (C-C motif) ligand 21; C-Raf1: serine-threonine kinases of the Raf family; FasL: Fas ligand; IL-2: interleukin-2; IL-4: interleukin-4; IL-18: interleukin-18; LIGHT: a member of TNF cytokine family; L1HPV16: capsid protein L1HPV16; MTDH: metadherin; NY-ESO-1: testis antigen; PSA: prostate-specific antigen; HPV16E7: human papillomavirus protein E7; TRAIL: TNF-related apoptosis-inducing ligand; TNF-α: tumor necrosis factor α; VEGFR-2: vascular endothelial growth factor receptor-2; NK: natural killer; IFN-γ: interferon γ.
|